Literature DB >> 15316172

Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.

H Yasuda1, Y Tomita, A Shibaki, T Hashimoto.   

Abstract

We describe two patients with psoriasis vulgaris who subsequently developed a subepidermal blistering disease which disclosed IgG and C3 at the basement membrane zone in direct immunofluorescence. The first case was a 75-year-old Japanese man with herpetiform lesions. Histopathology showed neutrophil infiltration. IgG antibodies bound to the dermal side of the salt-split skin. Immunoblot analysis identified a 200-kD antigen in dermal extracts. The second case was a 70-year-old Japanese man. Histopathology showed eosinophil infiltration. IgG antibodies bound to the epidermal side of salt-split skin. Immunoblot analysis identified a 180-kD bullous pemphigoid (BP) antigen in epidermal extracts. We review the clinical and pathological features of psoriatic patients who presented a subepidermal blistering disease in which antigens were detected by immunoblot analysis; i.e., anti-p200 pemphigoid (14 cases) or BP (12 cases). There were few distinct clinical differences between two diseases. However, neutrophils were predominant in anti-p200 pemphigoid, while eosinophils were predominant in BP. After blister formation, ciclosporin was used effectively in addition to systemic steroids in the treatment of anti-p200 pemphigoid. On the other hand, ciclosporin was not used in the treatment of BP with psoriasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316172     DOI: 10.1159/000079602

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

1.  Diseases mimicking a burn - outcome and treatment.

Authors:  O Castana; M Makrodimou; D Michelakis; Z Tsandoulas; D Alexakis
Journal:  Ann Burns Fire Disasters       Date:  2005-09-30

Review 2.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

3.  Anti-p200 Pemphigoid: A Systematic Review.

Authors:  Khalaf Kridin; A Razzaque Ahmed
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

4.  Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.

Authors:  Ying-Han Xie; Si-Hang Wang; Si-Zhe Li; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

5.  Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin.

Authors:  Xiaoqing Si; Lingzhi Ge; Hongyan Xin; Wang Cao; Xiaohui Sun; Wenfei Li
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.